The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome

Published:2024-04-23 Issue:1 Volume:17 Page:
ISSN:2689-5293
Container-title:All Life
language:en
Short-container-title:All Life

Author:

Chen Ying¹²,Wu Yue¹³,Chen Ting³⁴,Zou Duobing¹²,Shi Cong¹²,Wu Ningning¹²,Sheng Lixia²⁴,Ouyang Guifang²⁴,Mu Qitian¹²

Affiliation:

1. Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China

2. Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of China

3. Medical School, Ningbo University, Ningbo, People’s Republic of China

4. Hematology Department, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China

Funder

Medical and Health Science and Technology Projects of Zhejiang Province

Natural Science Foundation of Ningbo Municipality

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/26895293.2024.2343710

Reference32 articles.

1. Crucial players in glycolysis: Cancer progress

2. Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke

3. AST-to-ALT ratio in the first trimester and the risk of gestational diabetes mellitus

4. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

5. Myelodysplastic Syndromes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP